patent foramen ovale (PFO)
This clinical study is intended to demonstrate the safety and effectiveness of the AMPLATZERTM PFO Occluder, in a post approval setting, in patients with a PFO who have had a cryptogenic stroke confirmed by a study neurologist.
Principal Investigator: Srinivasa Potluri MD
IRB Number: 018-025
Trial Status: Enrolling
Exclusions: Age 18-60
Change in Care: Participating in this study will change your care in that you could have additional lab work, diagnostic imaging, and follow-up visits
Destiny Barnett, RN
Penni Dolton, RN
Amplatzer PFO Occluder Post Approval Study
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Scott & White Health's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Scott & White Health.